| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.3M | +71.1% |
| R&D Expense | $3.7M | +113.8% |
| SG&A Expense | $12.3M | +52.9% |
| Operating Income | -$27.0M | -70.0% |
| Interest Expense | $267K | -37.5% |
| Pre-tax Income | -$27.0M | -67.3% |
| Income Tax | -$521K | -247.4% |
| Net Income | -$26.5M | -65.6% |
| EPS (Basic) | -$1.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.8M | -28.2% |
| Accounts Receivable | $1.4M | +588.7% |
| Current Assets | $26.5M | -1.7% |
| Total Assets | $49.9M | +13.0% |
| Current Liabilities | $17.4M | +55.8% |
| Long-term Debt | $20.2M | — |
| Total Liabilities | $43.8M | +202.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.2M | -226.4% |
| Capital Expenditures | $363K | +32.7% |
| Investing Cash Flow | $32.4M | +236.2% |
| Financing Cash Flow | $196 | -100.0% |
| Free Cash Flow | -$35.6M | -221.6% |
| +17.6% |
| EPS (Diluted) | -$1.31 | +17.6% |
| Stockholders' Equity |
| $6.1M |
| -79.4% |